Cancer Precision Medicine in the Moreira Group

The Precision Cancer Medicine Group strives to identify cancer molecular biomarkers, applying omics technologies to maximize molecular insight into individual tumours. Patient tissue analysis complemented by model systems, animal as well as cellular, are used to accelerate drug development and enable individualized disease treatment and prevention.






















































Research Projects









Portrit of José Moreira

Group Leader

José Moreira

Phone +45 3533 3116

Group/project members

Name Title Phone E-mail